What are the major opportunities in the Rheumatic Heart Disease market? What are the strategies for the Rheumatic Heart Disease market?

For detailed insights on the major opportunities and strategies in the Rheumatic Heart Disease market, Read More

How does the Rheumatic Heart Disease market relate to the overall economy and other similar markets?

For detailed insights on Rheumatic Heart Disease's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Rheumatic Heart Disease market growth? SWOT analysis of the Rheumatic Heart Disease market.

For detailed insights on the key dynamics influencing the Rheumatic Heart Disease market growth and SWOT analysis of the Rheumatic Heart Disease industry, Read More

Global Rheumatic Heart Disease Market Report 2025

Item added to cart!

Report Price : $4490.00

Pages : 175

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Rheumatic Heart Disease Global Market Report 2025

Name: Rheumatic Heart Disease Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type (Valve, Myocarditis, Pericarditis), By Age Group (Pediatric, Adolescent, Adult, Geriatric), By Application (Hospital, Diagnostic Centre, Research Centre), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Direct Sales) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Rheumatic Heart Disease Market Overview

• Rheumatic Heart Disease market size has reached to $2.56 billion in 2024

• Expected to grow to $3.42 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%

• Growth Driver: Rising Prevalence of Strep Throat Driving The Growth Of The Market Due To Increasing Infection Rates And Antibiotic Resistance

• Market Trend: Strengthening Healthcare Access Through Public-Private Partnerships For Early Disease Detection And Treatment

• North America was the largest region in 2024.

What Is Covered Under Rheumatic Heart Disease Market?

Rheumatic heart disease (RHD) is a chronic heart condition caused by permanent damage to the heart valves due to rheumatic fever, an inflammatory disease resulting from untreated or inadequately treated streptococcal throat infections. The immune response triggered by the infection leads to inflammation and scarring of the heart valves, impairing their function and potentially causing heart failure, arrhythmias, or other complications.

The main types of rheumatic heart disease include valve-related disease, myocarditis, and pericarditis. Valve-related rheumatic heart disease occurs when rheumatic fever damages the heart valves, leading to impaired blood flow and complications such as stenosis or regurgitation. The impacted age groups encompass pediatric, adolescent, adult, and geriatric populations. Rheumatic heart disease is addressed and treated across multiple applications, such as hospitals, diagnostic centers, and research centers. The distribution channels for drugs include hospital pharmacies, retail pharmacies, online pharmacies, and direct sales.

Rheumatic Heart Disease Market Size and growth rate 2025 to 2029: Graph

What Is The Rheumatic Heart Disease Market Size 2025 And Growth Rate?

What Is The Rheumatic Heart Disease Market Growth Forecast?

The rheumatic heart disease market size is expected to see strong growth in the next few years. It will grow to $3.42 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to increasing adoption of preventive screening programs, growing awareness about early detection, rising healthcare investments in developing regions, expansion of telemedicine for remote diagnosis, government initiatives for disease prevention. Major trends in the forecast period include increasing use of AI in diagnostics, expansion of echocardiography-based screening, integration of mobile health solutions, development of novel anti-inflammatory therapies, collaborations for global disease eradication.

The forecast of 5.9% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for the U.S. by restricting access to cardiac valve replacements and penicillin prophylaxis drugs imported from Ireland and Brazil, potentially increasing post-surgical complication rates and raising cardiology care expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Rheumatic Heart Disease Market Segmented?

1) By Type: Valve, Myocarditis, Pericarditis

2) By Age Group: Pediatric, Adolescent, Adult, Geriatric

3) By Application: Hospital, Diagnostic Centre, Research Centre

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Direct Sales

Subsegments:

1) By Valve: mitral valve disease, Aortic Valve Disease, Tricuspid Valve Disease, Pulmonary Valve Disease

2) By Myocarditis: Acute Myocarditis, Chronic Myocarditis, Fulminant Myocarditis

3) By Pericarditis: Acute Pericarditis, Chronic Pericarditis, Constrictive Pericarditis, Effusive Pericarditis

What Is Driving The Rheumatic Heart Disease Market? Rising Prevalence of Strep Throat Driving The Growth Of The Market Due To Increasing Infection Rates And Antibiotic Resistance

The increasing prevalence of strep throat is expected to propel the growth of the rheumatic heart disease market going forward. Strep throat refers to a bacterial infection caused by streptococcus pyogenes (group a streptococcus) it leads to inflammation and pain in the throat, often accompanied by fever, swollen lymph nodes, and difficulty swallowing. Rising antibiotic resistance is making streptococcal infections harder to treat effectively, which leads to prolonged illness and higher transmission rates in communities. Rheumatic heart disease develops as a long-term complication of untreated or recurrent strep throat infections, highlighting the importance of early diagnosis and treatment of streptococcal infections to prevent severe heart damage. For instance, in April 2023, according to the Centers for Disease Control and Prevention, a US-based government department, strep throat accounts for an estimated 5.2 million outpatient visits annually among individuals younger than 65 years old. These visits lead to 2.8 million antibiotic prescriptions each year. Therefore, the increasing prevalence of strep throat is driving the growth of the rheumatic heart disease industry.

Who Are The Major Players In The Global Rheumatic Heart Disease Market?

Major companies operating in the rheumatic heart disease market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis AG, Abbott Laboratories, GlaxoSmithKline plc (GSK), Medtronic plc, Siemens Healthineers AG, Fresenius Medical Care AG & Co. KGaA, Becton Dickinson and Company (BD), GE HealthCare Technologies Inc., Mayo Clinic, Boston Scientific Corporation, Johns Hopkins Medicine, Terumo Corporation, The Mount Sinai Health System Inc., Apollo Hospitals Enterprise Limited, Fortis Healthcare Limited, Medanta.

What Are The Key Trends Of The Global Rheumatic Heart Disease Market? Strengthening Healthcare Access Through Public-Private Partnerships For Early Disease Detection And Treatment

Major companies operating in the rheumatic heart disease market are adopting a strategic partnership approach to develop innovative treatments and diagnoses. Strategic partnerships in the rheumatic heart disease (RHD) management unite resources and expertise to advance research and development, enhance diagnostic and therapeutic innovations, expand market penetration, and fast-track commercialization. For instance, in July 2023, the World Heart Federation (WHF), a Switzerland-based non-governmental organization, partnered with the Philips Foundation, a Netherlands-based nonprofit organization, to improve awareness, medical training, and early detection of rheumatic heart disease (RHD) in the Asia-Pacific (APAC) region. Launched in the Philippines, the initiative seeks to enhance healthcare access for over half a million at-risk Filipino children by equipping facilities with trained professionals and advanced diagnostic tools. This collaboration underscores a joint commitment to strengthening healthcare infrastructure and ensuring timely intervention for RHD patients.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Rheumatic Heart Disease Market? Light AI Inc. Partners With Mrbeast Industries To Donate AI-Powered Strep A Tests In Africa For Early Disease Prevention

In February 2025, Light AI Inc., a Canada-based healthcare technology company, partnered with MrBeast Industries to support global health initiatives. This collaboration focuses on donating AI-powered Strep A tests across Africa, enabling early detection and prevention of the disease to reduce the risk of severe complications such as rheumatic heart disease. MrBeast Industries is a US-based media and entertainment company that focuses on digital content creation.

What Is The Regional Outlook For The Global Rheumatic Heart Disease Market?

North America was the largest region in the rheumatic heart disease market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Rheumatic Heart Disease Market?

The rheumatic heart disease market consists of revenues earned by entities by providing services such as surgical treatments, diagnostic tests, preventive care services, and pediatric care services. The market value includes the value of related goods sold by the service provider or included within the service offering. The rheumatic heart disease market also includes sales of antibiotics, anti-inflammatory medications, diuretics, beta-blockers, and ACE inhibitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Rheumatic Heart Disease Industry?

The rheumatic heart disease market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the rheumatic heart disease industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Rheumatic Heart Disease Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$2.71 billion
Revenue Forecast In 2034	$3.42 billion
Growth Rate	CAGR of 5.9% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The rheumatic heart disease market covered in this report is segmented – 1) By Type: Valve, Myocarditis, Pericarditis 2) By Age Group: Pediatric, Adolescent, Adult, Geriatric 3) By Application: Hospital, Diagnostic Centre, Research Centre 4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Direct Sales Subsegments: 1) By Valve: Mitral Valve Disease, Aortic Valve Disease, Tricuspid Valve Disease, Pulmonary Valve Disease 2) By Myocarditis: Acute Myocarditis, Chronic Myocarditis, Fulminant Myocarditis 3) By Pericarditis: Acute Pericarditis, Chronic Pericarditis, Constrictive Pericarditis, Effusive Pericarditis
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Request for Sample
Customization Scope	Explore Purchase Options
Pricing And Purchase Options

1. Executive Summary

2. Rheumatic Heart Disease Market Characteristics

3. Rheumatic Heart Disease Market Trends And Strategies

4. Rheumatic Heart Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Rheumatic Heart Disease Growth Analysis And Strategic Analysis Framework

5.1. Global Rheumatic Heart Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Rheumatic Heart Disease Market Growth Rate Analysis

5.4. Global Rheumatic Heart Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Rheumatic Heart Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Rheumatic Heart Disease Total Addressable Market (TAM)

6. Rheumatic Heart Disease Market Segmentation

6.1. Global Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Valve

Myocarditis

Pericarditis

6.2. Global Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pediatric (0-14 Years)

Adolescent (15-24 Years)

Adult (25-64 Years)

Geriatric (65 Years And Above)

6.3. Global Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital

Diagnostic Centre

Research Centre

6.4. Global Rheumatic Heart Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Direct Sales

6.5. Global Rheumatic Heart Disease Market, Sub-Segmentation Of Valve, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Mitral Valve Disease

Aortic Valve Disease

Tricuspid Valve Disease

Pulmonary Valve Disease

6.6. Global Rheumatic Heart Disease Market, Sub-Segmentation Of Myocarditis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Acute Myocarditis

Chronic Myocarditis

Fulminant Myocarditis

6.7. Global Rheumatic Heart Disease Market, Sub-Segmentation Of Pericarditis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Acute Pericarditis

Chronic Pericarditis

Constrictive Pericarditis

Effusive Pericarditis

7. Rheumatic Heart Disease Market Regional And Country Analysis

7.1. Global Rheumatic Heart Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Rheumatic Heart Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Rheumatic Heart Disease Market

8.1. Asia-Pacific Rheumatic Heart Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Rheumatic Heart Disease Market

9.1. China Rheumatic Heart Disease Market Overview

9.2. China Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Rheumatic Heart Disease Market

10.1. India Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Rheumatic Heart Disease Market

11.1. Japan Rheumatic Heart Disease Market Overview

11.2. Japan Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Rheumatic Heart Disease Market

12.1. Australia Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Rheumatic Heart Disease Market

13.1. Indonesia Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Rheumatic Heart Disease Market

14.1. South Korea Rheumatic Heart Disease Market Overview

14.2. South Korea Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Rheumatic Heart Disease Market

15.1. Western Europe Rheumatic Heart Disease Market Overview

15.2. Western Europe Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Rheumatic Heart Disease Market

16.1. UK Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Rheumatic Heart Disease Market

17.1. Germany Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Rheumatic Heart Disease Market

18.1. France Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Rheumatic Heart Disease Market

19.1. Italy Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Rheumatic Heart Disease Market

20.1. Spain Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Rheumatic Heart Disease Market

21.1. Eastern Europe Rheumatic Heart Disease Market Overview

21.2. Eastern Europe Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Rheumatic Heart Disease Market

22.1. Russia Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Rheumatic Heart Disease Market

23.1. North America Rheumatic Heart Disease Market Overview

23.2. North America Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Rheumatic Heart Disease Market

24.1. USA Rheumatic Heart Disease Market Overview

24.2. USA Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Rheumatic Heart Disease Market

25.1. Canada Rheumatic Heart Disease Market Overview

25.2. Canada Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Rheumatic Heart Disease Market

26.1. South America Rheumatic Heart Disease Market Overview

26.2. South America Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Rheumatic Heart Disease Market

27.1. Brazil Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Rheumatic Heart Disease Market

28.1. Middle East Rheumatic Heart Disease Market Overview

28.2. Middle East Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Rheumatic Heart Disease Market

29.1. Africa Rheumatic Heart Disease Market Overview

29.2. Africa Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Rheumatic Heart Disease Market Competitive Landscape And Company Profiles

30.1. Rheumatic Heart Disease Market Competitive Landscape

30.2. Rheumatic Heart Disease Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

31. Rheumatic Heart Disease Market Other Major And Innovative Companies

31.1. Novartis AG

31.2. Abbott Laboratories

31.3. GlaxoSmithKline plc (GSK)

31.4. Medtronic plc

31.5. Siemens Healthineers AG

31.6. Fresenius Medical Care AG & Co. KGaA

31.7. Becton Dickinson and Company (BD)

31.8. GE HealthCare Technologies Inc.

31.9. Mayo Clinic

31.10. Boston Scientific Corporation

31.11. Johns Hopkins Medicine

31.12. Terumo Corporation

31.13. The Mount Sinai Health System Inc.

31.14. Apollo Hospitals Enterprise Limited

31.15. Fortis Healthcare Limited

32. Global Rheumatic Heart Disease Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Rheumatic Heart Disease Market

34. Recent Developments In The Rheumatic Heart Disease Market

35. Rheumatic Heart Disease Market High Potential Countries, Segments and Strategies

35.1 Rheumatic Heart Disease Market In 2029 - Countries Offering Most New Opportunities

35.2 Rheumatic Heart Disease Market In 2029 - Segments Offering Most New Opportunities

35.3 Rheumatic Heart Disease Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Rheumatic Heart Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Rheumatic Heart Disease Market, Sub-Segmentation Of Valve, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Rheumatic Heart Disease Market, Sub-Segmentation Of Myocarditis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Rheumatic Heart Disease Market, Sub-Segmentation Of Pericarditis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Rheumatic Heart Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Rheumatic Heart Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Pfizer Inc. Financial Performance

Table 79: Merck & Co. Inc. Financial Performance

Table 80: Bayer AG Financial Performance

Table 81: Sanofi S.A. Financial Performance

Table 82: AstraZeneca plc Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Rheumatic Heart Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Rheumatic Heart Disease Market, Sub-Segmentation Of Valve, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Rheumatic Heart Disease Market, Sub-Segmentation Of Myocarditis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Rheumatic Heart Disease Market, Sub-Segmentation Of Pericarditis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Rheumatic Heart Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Rheumatic Heart Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Pfizer Inc. Financial Performance

Figure 79: Merck & Co. Inc. Financial Performance

Figure 80: Bayer AG Financial Performance

Figure 81: Sanofi S.A. Financial Performance

Figure 82: AstraZeneca plc Financial Performance

Top Trends Driving Innovation and Change in the Interstitial Lung Disease Market: Innovative Drug Development Initiatives To Improve Interstitial Lung Disease Treatment

Global Intestinal Pseudo-Obstruction Treatment Market Projected to Reach $30.8 Billion by 2029 at a CAGR of 5.6%

Key Developments and Trends Steering the Intestine Cancer Therapeutics Market Forward: Increasing Focus On Product Approvals To Drive The Revenues

Major Trends and Emerging Patterns in the Intravenous Solutions Market: Innovative Syringes Transforming The Intravenous Solutions Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Heart Attack Diagnostic Global Market Report 2025 – By Test Type( Electrocardiogram (ECG/EKG), Blood Tests, X-Ray, Echocardiogram, Coronary Catheterization (Angiogram), Exercise Stress Test, Magnetic Resonance Imaging (M...

Peripheral Artery Disease Global Market Report 2025 – By Type (Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alt...

Peripheral Arterial Disease Global Market Report 2025 – By Treatment Type (Devices, Catheters, Drugs, Other Types), By Route of Administration (Oral, Parenteral, Other Route of Administrations), By End User (Hospitals, S...

Cardiac Valve Global Market Report 2025 – By Type (Tissue Heart Valves, Transcatheter Heart Valves, Mechanical Heart Valves, Other Types), By Position (Aortic Valve, Mitral Valve, Other Positions), By Treatment (Cardiac ...

Coronary Artery Disease Global Market Report 2025 – By Treatment (Medication, Surgery, Additional Therapy, Other Treatments), By Diagnosis (Electrocardiogram, Echocardiogram, Stress Test, Cardiac Catheterization, Heart C...

Congenital Heart Disease (CHD) Global Market Report 2025 – By Type (Heart Valve Defects, Heart Wall Defects, Blood Vessel Defects, Other Types), By Diagnosis (Electrocardiogram, Chest X-ray, Echocardiogram, Transesophag...

Pericarditis Global Market Report 2025 – By Type (Acute Pericarditis, Chronic Pericarditis, Recurrent Pericarditis ), By Diagnosis And Treatment (Electrocardiogram (ECG), Echocardiogram, Computerized Tomography (CT), X-R...

Frequently Asked Questions

What is the definition of the Rheumatic Heart Disease market?

How will the Rheumatic Heart Disease market drivers and restraints affect the market dynamics? What forces will shape the Rheumatic Heart Disease industry going forward?

The market major growth driver - Rising Prevalence of Strep Throat Driving The Growth Of The Market Due To Increasing Infection Rates And Antibiotic Resistance. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Rheumatic Heart Disease market?

The rheumatic heart disease market size has grown strongly in recent years. It will grow from $2.56 billion in 2024 to $2.71 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to the prevalence of untreated strep infections, limited access to healthcare in low-income regions, lack of awareness about rheumatic heart disease, delayed diagnosis and treatment, and inadequate vaccination programs. The rheumatic heart disease market size is expected to see strong growth in the next few years. It will grow to " $3.42 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to increasing adoption of preventive screening programs, growing awareness about early detection, rising healthcare investments in developing regions, expansion of telemedicine for remote diagnosis, government initiatives for disease prevention. Major trends in the forecast period include increasing use of AI in diagnostics, expansion of echocardiography-based screening, integration of mobile health solutions, development of novel anti-inflammatory therapies, collaborations for global disease eradication. For further insights on this market, request a sample here

How is the Rheumatic Heart Disease market segmented?

The rheumatic heart diseasemarket covered in this report is segmented –
1) By Type: Valve; Myocarditis; Pericarditis
2) By Age Group: Pediatric; Adolescent; Adult; Geriatric
3) By Application: Hospital; Diagnostic Centre; Research Centre
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Direct Sales Subsegments:
1) By Valve: Mitral Valve Disease; Aortic Valve Disease; Tricuspid Valve Disease; Pulmonary Valve Disease
2) By Myocarditis: Acute Myocarditis; Chronic Myocarditis; Fulminant Myocarditis
3) By Pericarditis: Acute Pericarditis; Chronic Pericarditis; Constrictive Pericarditis; Effusive Pericarditis For further insights on this market, request a sample here

Which region has the largest share of the Rheumatic Heart Disease market? What are the other regions covered in the report?

North America was the largest region in the rheumatic heart disease market in 2024. The regions covered in the rheumatic heart disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Rheumatic Heart Disease market?

What are the key trends in the Rheumatic Heart Disease market?

Major trends in this market include Strengthening Healthcare Access Through Public-Private Partnerships For Early Disease Detection And Treatment. For further insights on this market, request a sample here.